Scientists use Stephen Hawking theory to slash universe's life expectancy
A team of three scientists from Radboud University, Netherlands, calculated how long it would take for black holes, neutron stars, and other objects to "evaporate" via a process similar to Hawking radiation.
Their research, which builds on previous work by the same team, shows that the last stellar remnants of the universe will take roughly 1078 years to perish. That is much shorter than the 101100 years scientists previously calculated.
The team behind the new calculations used Hawking radiation as a basis for their research. In 1975, British theoretical physicist Professor Stephen Hawking theorized that some material escapes the event horizon of black holes.
This phenomenon, explained via quantum mechanics, ultimately meant that black holes slowly decay into particles and radiation. This contradicted Albert Einstein's theory of relativity, which states that black holes do not decay.
The new research findings, carried out by black hole expert Heino Falcke, quantum physicist Michael Wondrak, and mathematician Walter van Suijlekom, were published in a paper in the Journal of Cosmology and Astroparticle Physics.
The new research is a follow-up to a 2023 paper by the same team. In that paper, they showed that some of the universe's most ancient objects, including black holes and neutron stars, can also evaporate via a process akin to Hawking radiation.
After publishing that paper, the team researched how long this process could take. Based on their calculations, they believe the end of the universe is roughly 1078 years away. That is, if only Hawking-like radiation is taken into consideration.
To reach that number, the team calculated how long it would take a white dwarf star, the most persistent celestial body in the universe, to decay via Hawking-like radiation. Previous studies have suggested white dwarfs could have a lifetime of 101100 years.
In a press release, Lead author Heino Falcke said: "So the ultimate end of the universe comes much sooner than expected, but fortunately it still takes a very long time."
Though Hawking's radiation theory specifically applies to Black Holes, the team from Radboud University believes the process applies to other objects with a gravitational field. Their calculations showed that the evaporation time of an object depends only on its density.
Although it shows our universe may have a shorter lifetime than previously believed, the research highlights what a dizzyingly long time the universe could last – the 1078 in their calculations amounts to 1 and 78 zeroes.
The team also performed a few extra tongue-in-cheek calculations. They found that the Moon and a human would take 1090 years to evaporate via Hawking-like radiation.
However, the team believes their research could shed new light on the cosmos. Walter van Suijlekom noted: "By asking these kinds of questions and looking at extreme cases, we want to understand the theory better, and perhaps one day, we will unravel the mystery of Hawking radiation."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
32 minutes ago
- Medscape
Digital Twins: Medicine's New Crystal Ball?
Digital twins are rapidly emerging as powerful tools in personalized medicine and beyond. In healthcare, they serve as virtual representations of a patient's body, body parts, specific organs, and systems, such as the circulatory and nervous systems. Functional modeling of the state and behavior of the body or its components has the potential to provide information for clinical and research applications. The goal is to simulate how an organ, system, or even the entire body responds to stimuli and circumstances of clinical relevance to the patient, thereby deriving useful conclusions. These models may be descriptive, predictive, prescriptive, or even generative, capable of filling in missing or unavailable data. A central challenge is accurately replicating the physicochemical, physiological, anatomical, and, when needed, psychological attributes relevant to each specific use case. Building clinically useful digital twins depends on integrating diverse data sources, which is a technically complex task. However, when successful, it enables a dynamic 'dialogue' with the model to evaluate its current state, forecast evolution, and simulate responses to interventions such as therapies. It is important to emphasize that digital twin simulations are tailored to individual patients — they do not represent a generic or archetypal patient but instead aim to create a personalized model for a specific individual. One example is a project led by the Spanish National Cancer Research Centre (CNIO), which is developing digital twins of women with advanced cancer using artificial intelligence. This initiative, titled 'High-Definition Oncology in Women's Cancer,' is part of the Precision Medicine Infrastructure Associated With Science and Technology program. These digital twins consist of multiple layers of information integrated into a single model that reflects reality for a specific application. In the aforementioned project, a wide range of data were incorporated into the digital twin models, spanning tumor metabolism, gene and protein expression, physiological indicators such as circadian rhythms, heart rate, and physical activity, emotional well-being, and conventional clinical data from diagnostics to treatment protocols. Adding more 'layers' of information enhances the model complexity and accuracy, enabling incremental improvements and expanded functionality. A notable innovation in this case is the biological clock model developed by the CNIO, which estimates a patient's biologic age. This can help assess whether biologic aging accelerates or slows during disease progression, providing insight into the effect of treatment. This may guide clinicians in adjusting treatment intensity or modifying therapeutic combinations according to the patient's evolving biologic state. The layers of information used and their integration are key aspects of each type of digital twin, ensuring that it is not only functional but also clinically relevant. In many ways, digital twins serve as 'maps,' both literal and figurative. In the most direct sense, they can guide the planning of physical interventions such as surgical procedures. Broader Applications In addition to simulating the effects of therapies, digital twins can model the natural progression of diseases and support long-term care planning. They may help anticipate the onset of certain conditions, particularly hereditary diseases, when risk factors are present but symptoms have yet to appear. These models offer valuable tools for proactive risk prevention and management. In the context of prevention, the ability to present a stronger, data-driven case — even if derived from simulations — could help persuade patients and improve adherence to preventive care guidelines. Integration With Medical Devices From a certain perspective, digital twins resemble a technology-driven 'crystal ball.' Once refined, these models could allow clinicians to explore alternative therapeutic scenarios and identify the most effective treatment strategies. This minimizes reliance on trial and error, enabling faster data-driven decisions in a controlled simulation environment, a kind of clinical sandbox. A key area of synergy lies between the digital twins and medical devices. Wearable technologies, for instance, can supply real-time or periodic health data that dynamically update a patient's digital twin. Conversely, digital twins can enhance the medical device field by enabling the optimization of device configurations or implant placements. Their integration into the body and potential physiological effects can be modeled and simulated in advance, allowing for more precise and personalized interventions. These models also help to synthesize and manage large volumes of complex data. By serving as intelligent filters, they reduce the cognitive load on clinicians, offering clear visualizations and simulations that support more confident decision-making, especially in complex or uncertain clinical situations. Applications and Regulatory Considerations Digital twins hold promise across a wide range of medical applications, from early diagnosis, prognosis, and personalized therapy selection to treatment monitoring and relapse prevention. In fields such as neurology, cardiology, and oncology, these models have already shown potential. Digital twins have already been applied in neurology, cardiology, and oncology. Focusing on Spain-based developments, two recent advances featured by Univadis Spain , a Medscape Network platform, stand out: One involves using digital twins for research on the human brain to uncover mechanisms linked to psychosis remission, and the other demonstrates the use of digital twin improvements in the diagnosis of premature ventricular contractions. While the field is evolving rapidly, it remains in its early stages. Although technical hurdles and regulatory complexities are expected, the long-term potential is significant. Digital twins could enable faster and safer evaluations of multiple treatment paths and support virtual experimentation in a risk-free environment. One major challenge is clinical validation. Digital twins must be tested with real-world longitudinal data and demonstrate that their predictions provide added value compared to current clinical guidelines. Equally crucial is the development of interoperable, cross-border data infrastructure that enables scalable, coordinated adoption across healthcare systems worldwide. A final and crucial aspect to consider is data privacy, ownership, and ethical use of digital twins. Beyond the data itself, fundamental questions arise about digital twin models: Who owns a person's digital twin? Should these models be transferable, and if so, under what conditions? Informed consent is central to addressing these issues and ensuring the responsible use of digital twin technologies in clinical practice. The use of digital twins in clinical trials is already being explored, and their potential extends further to medical training and patient education, particularly in explaining therapeutic options. As technology evolves, the range of future applications continues to expand.
Yahoo
3 hours ago
- Yahoo
Scientists develop extremely thin material that could usher in next-gen fuel source: 'Taking into account the global challenges'
Norwegian experts are making an already thin component for hydrogen fuel cells even slimmer to reduce the cost of the cleaner energy source, according to a news release on the breakthrough. The research is happening at SINTEF, an independent institute in Norway. Fuel cells work sort of like a battery, with similar parts. They convert hydrogen's chemical energy into electricity, water, and heat, according to the U.S. Department of Energy. As part of its criticism of the fuel, Sierra Club has noted that using hydrogen in a cell instead of burning it to produce energy eliminates harmful fume pollution. Cleaner hydrogen made through renewably powered electrolysis is also more planet-friendly than the standard production process that uses fossil fuels. However, fuel cells are expensive to produce, in large part because of costly components that include platinum. The Norwegian team addressed the issue with smaller parts, per the release. "By reducing the amount of platinum in the fuel cell, we're not only helping to reduce costs, we're also taking into account the global challenges regarding the supply of important raw materials and sustainability," researcher Patrick Fortin said in the release. The membrane and catalyst account for 41% of a fuel cell's cost, which is why the team focused on them. The membrane being studied is made of a polymer that is considered a PFAS, or forever chemical, that can have a lasting, negative impact on people and the environment. The researchers cut membrane thickness by 33% — making a sheet of paper seem like cardboard by comparison — reducing pollution as well as 20% of the costs, per the release. On the platinum front, the team figured out a better way to arrange the costly metal's particles to produce the most energy with the least amount of material. Platinum particles are like microscopic reactors "that [convert] hydrogen into electricity," the experts added. They were able to cut platinum content by more than 62% with some rearranging. Fuel cells are already powering superyachts, larger ships, and even helicopters. Researchers elsewhere are also working to make the tech more accessible. If fuel cells can replace combustion engines across multiple sectors, it could greatly help to clear the air. Transportation accounts for nearly 30% of U.S. planet-warming fume output, and tailpipe exhaust increases the risk of cancer and other health problems, per the Environmental Protection Agency. Should the U.S. invest more in battery innovations? Absolutely Depends on the project We're investing enough We should invest less Click your choice to see results and speak your mind. Battery-powered electric vehicles are a great, reliable switch already available. Better yet, tax breaks remain to offset up to $7,500 of the cost. You can also plan to save around $1,500 annually in gas and maintenance expenses. Even driving more efficiently, by eliminating idling, can cut pollution and save you cash. In Norway, the experts think their invention can soon have a big impact for scaling fuel cells. "If the innovations are put into practice, our research will contribute to making future clean energy technologies — like powerful … fuel cells — cheaper and more sustainable," Fortin said in the release. Join our free newsletter for weekly updates on the latest innovations improving our lives and shaping our future, and don't miss this cool list of easy ways to help yourself while helping the planet.
Yahoo
3 hours ago
- Yahoo
European Commission aims for quantum dominance
The European Commission has introduced a new plan to position Europe as a dominant force in the quantum technology sector by 2030. This initiative seeks to develop a robust and independent quantum ecosystem that will support startup growth and help transform scientific discoveries into market-ready applications. Quantum technology, with better processing speeds compared to conventional computing, is expected to address complex challenges. This includes advancements in pharmaceuticals and securing critical infrastructure. These technologies are also anticipated to enhance the EU's industrial competitiveness and technological sovereignty, with notable implications for defence and security. European Commission estimates that the sector will create thousands of skilled jobs across the EU and surpass a global valuation of €155bn ($183bn) by 2040. The new strategy particularly targets five primary areas: research and innovation, quantum infrastructures, ecosystem development, space and dual-use technologies, and quantum skills. The planned actions will include launching the Quantum Europe Research and Innovation Initiative with EU Member States to support foundational research and develop applications in crucial public and industrial sectors. Additionally, a quantum design facility and six quantum chip pilot lines will be established to convert scientific prototypes into manufacturable products. The strategy also includes plans to launch a pilot facility for the European Quantum Internet and expand the network of Quantum Competence Clusters across the EU. The European Quantum Skills Academy is expected to be established by 2026. The plan also envisages a collaboration with the European Space Agency for the development of a Quantum Technology Roadmap in Space. A significant aim of the strategy is to boost the share of global private funding that European quantum companies receive. The figure currently stands at approximately 5%. 'We have to now focus more on private funding because we are very strong already in public funding,' EU tech chief Henna Virkkunen was quoted by Reuters as saying in a press conference. In the past five years, the European Commission and EU countries have provided more than €11bn in public funding for quantum technology. The commission intends to work closely with Member States and the European quantum community, including academia, startups, industrial actors, and innovation stakeholders, to achieve the strategy's objectives. A High-Level Advisory Board, comprising leading European quantum scientists and technology experts, will offer independent strategic guidance on implementing the Quantum Europe Strategy. This will be followed by a Quantum Act proposal, expected in 2026, to further build on the strategy. "European Commission aims for quantum dominance" was originally created and published by Verdict, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data